Alopecia areata

European Journal of Dermatology

Volumn 6, Issue 7, 1996, Pages 471-478

  Montazeri, Ashraf ^a   Serre, Guy ^a   Kanitakis, Jean ^b  

^a CHU PURPAN   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Alopecia areata

Indexed keywords

CYCLOSPORIN A; DIPHENCYPRONE; METHISOPRINOL; MINOXIDIL; PSORALEN; STEROID;

ALOPECIA AREATA; FAMILIAL DISEASE; FEMALE; HUMAN; MALE; REVIEW;

EID: 0029949650     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (108)

1. Dawber RP, Ebling FJ, Wojnarowska F. Disorders of hair. In: Champion RH, Burton JL, Ebling FJG, eds. Textbook of Dermatology. Blackwell Sci. Publ., London, 1992, 2586-95.
2. Price VH. Alopecia areata: clinical aspects. J Invest Dermatol 1991; 96: 685.
3. Peereboon-Wynia JD, Beek CH, Mulder PG, Stolz E. The trichogram as a prognostic tool in alopecia areata. Acta Derm Venereol (Stockh) 1993; 73: 280-2.
4. Muller SA, Winkelmann RK. Alopecia areata. Arch Dermatol 1963; 88: 290-7.
5. Lenvers P, Mauduit G, Cambazard F. Physiopathologie et traitement de la pelade. Ann Dermatol Vénéréal 1987; 114: 73-83.
6. Jackson D, Church RE, Ebling FJ. Alopecia areata hairs. A scanning electron microscopic study. Br J Dermatol 1971; 85: 242-6.
7. Peereboom-Wynia JD, Koretn HK, van Joost TH, Stolz E. Scanning electron microscopy comparing exclamation mark hairs in alopecia areata with normal hair fibres mechanically broken by traction. Clin Exp Dermatol 1989; 14: 47-50.
8. Ikeda T. A new classification of alopecia areata. Dermatologica 1965; 113: 421-45.
9. Walker SA, Rothman S. Alopecia areata. A statistical study and consideration of endocrine influences. J Invest Dermatol 1950; 14: 403-12.
10. Scerri L, Pace JL. Identical twins with identical alopecia areata. J Am Acad Dermatol 1992; 27: 766-7.
11. Goldsmith LA. Summary of the second international research workshop on alopecia areata. J Invest Dermatol 1995; 104: 2S-3S.
12. Duvic M, Hordinsky MK, Fiedler VC, O'Brien WR, Young R, Reveille JD. HLA-D Locus associations in alopecia areata: DRw52a may confer disease resistance. Arch Dermatol 1991; 127: 64-8.
13. Abdel-Naser MB, Blume-Peytavi U, Abdel-Fatah A, Orfanos CE. Evidence for a complement-mediated inhibition and an antibody-dependent cellular cytotoxicity of dermal fibroblasts in alopecia areata. Acta Derm Venereol (Stockh) 1994; 74: 351-4.
14. Baadsgaard O. Alopecia areata: an immunologic disease? J Invest Dermatol 1991; 96: 89S-90S.
15. Frentz G, Thomsen K. HLA-DR4 in alopecia areata. J Am Acad Dermatol 1986; 14: 129-30.
16. McDonagh AJ, Snowden JA, Stierle C, Elliott K, Messenger AG. HLA and ICAM-1 Expression in alopecia areata in vivo and in vitro: the role of cytokines. Br J Dermatol 1993; 129: 250-6.
17. Milgraum SS, Mitchell AJ, Bacon GE, Rasmussen JE. Alopecia areata, endocrine function, and autoantibodies in patients 16 years of age or younger. J Am Acad Dermatol 1987; 17: 57-61.
18. Baran R, Dawber RP, eds. Diseases of the nails and their management. Oxford: Blackwell Sci Publ, 1984, 192-5.
19. De-Waard-Van der Spek FB, Oranje AP, De Raeymaeker DM, Peereboon-Wynia JD. Juvenile versus maturity-onset alopecia areata- a comparative retrospective clinical study. Clin Exp Dermatol 1989; 14: 429-33.
20. Baran R, Dupré A, Christol B, Bonafé JL, Sayag J, Ferrère J. Ongle grésé peladique. Ann Dermatol Vénéréol 1978; 105: 387-92.
21. Tosti A, Morelli R, Bardazzi F, Peluso AM. Prevalence of nail abnormalities in children with alopecia areata. Pediatr Dermatol 1994; 11: 112-5.
22. Tosti A, Bardazzi F, Piraccini BM, Fanti PA, Cameli N, Pileri S. Is trachyonychia, a variety of alopecia areata, limited to the nails? J Invest Dermatol 1995; 104: 275-85.
23. Langhof H, Lenke L. Ophthalmologische Befunde bei Alopecia Areata. Dermatol Wochenschr 1962; 146: 585-8.
24. Tosti A, Colombati S, Caponeri GM. Ocular abnormalities occurring with alopecia areata. Dermatologica 1985; 170: 69-73.
25. Muller HK, Rook AJ, Kubba R. Immunohistology and autoantibody studies in alopecia areata. Br J Dermatol 1980; 102: 609-15.
26. Fiedler-Weiss VC, Buys CM. Response to minoxidil in severe alopecia areata correlates with T lymphocyte stimulation. Br J Dermatol 1987; 117: 759-63.
27. Gilhar A, Krueger GG. Hair growth in scalp grafts from patients with alopecia areata and alopecia universalis grafted onto nude mice. Arch Dermatol 1987; 123: 44-50.
28. Gilhar A, Pillar T, Assay B, David M. Failure of passive transfer of serum from patients with alopecia areata and alopecia universalis to inhibit hair growth in transplants of human scalp skin grafted onto nude mice. Br J Dermatol 1992; 126: 166-71.
29. + cells in alopecia areata after corticosteroid therapy. Dermatology 1994; 188: 103-7.
30. Johansson E, Ranki A, Reunala T, Kianto U, Niemi KM. Immunohistological evaluation of alopecia areata treated with squaric acid dibutylester (SADBE). Acta Derm Venereol (Stockh) 1986; 66: 485-90.
31. Khoury EL, Price VH, Greenspan JS. HLA-DR Expression by hair follicle keratinocytes in alopecia areata: evidence that it is secondary to the lymphoid infiltration. J Invest Dermatol 1988; 90: 193-200.
32. Lutz G, Niedecken H, Bauer R, Kreysel HW. Two-color flow cytometry analysis in alopecia areata. Dermatologica 1989; 178: 64-6.
33. MacDonald-Hull S, Nutbrown M, Pepall L, Thornton MJ, Randall VA, Cunliffe WJ. Immunohistologic and ultrastructural comparison of the dermal papilla and hair follicle bulb from "active" and "normal" areas of alopecia areata. J Invest Dermatol 1991; 96: 673-81.
34. Tobin DJ, Orentreich N, Fenton DA, Bystryn JC. Antibodies to hair follicles in alopecia areata. J Invest Dermatol 1994; 102: 721-4.
35. Valsecchi R, Imberti G, Martino D, Cainelli T. Alopecia areata and interleukin-2 receptor. Dermatology 1992; 184: 126-8.
36. Friedmann PS. Alopecia areata and autoimmunity. Br J Dermatol 1981; 105: 153-7.
37. Van der Steen P, Troupe H, Happle R, Boezeman J, Sträter R, Hamm H. The genetic risk for alopecia areota in first degree relatives of severely affected patients: an estimate. Acta Derm Venereol (Stockh) 1992; 72: 373-5.
38. Cork MJ, Tarlow JK, Clay FE, Crane A, Blakemore AIF, McDonagh AJG, Messenger AG, Duff GW. An allele of the interleukin-1 receptor antagonist as a genetic severity factor in alopecia areata. J Invest Dermatol 1995; 104: 15s-6s.
39. Weidmann AI, Zion LS, Mamelok AE. Alopecia areata occurring simultaneously in identical twins. Arch Dermatol 1956; 74: 424-32.
40. Arnold HL. Alopecia areata: prevalence in Japanese and prognosis after reassurance. Arch Dermatol Syphilol 1952; 66: 191-7.
41. Orecchia G, Guccia Belvedere M, Martinetti M, Capelli E, Rabbiosi G. Human leukocyte antigen region involvement in the genetic predisposition to alopecia areata. Dermatologica 1987; 175: 10-4.
42. Colombe BW, Price VH, Khoury EL, Lou CD. HLA class II alleles in long-standing alopecia totalis/alopecia universalis and long-standing patchy alopecia areata differentiate these two clinical groups. J Invest Dermatol 1995; 104: 4S-5S.
43. Duvic M, Welsh EA, Jackow C, Papadopoulos E, Reveille JD, Amos C. Analysis of HLA-D locus alleles in alopecia areata patients and families. J Invest Dermatol 1995; 104: 5S-6S.
44. Colombe BW, Price VH, Khoury EL, Garovoy M, Lou CD. HLA class II antigen associations help to define two types of alopecia areata. J Am Acad Dermatol 1995; 33: 757-64.
45. Van Der Steen P, Boezeman J, Duller P, Happle R. Can alopecia areata be triggered by emotional stress? Acta Derm Venereol (Stockh) 1992; 72: 279-80.
46. Ferraro S. II Bernereuter personality inventory in ammelati di area Celsi. Clinical Dermatol 1979; 10: 51-5.
47. Tobin DJ, Bystryn JC. Immunity to hair follicles in alopecia areata. J Invest Dermatol 1995; 104: 13S-4S.
48. Randall NS, Calver NS, MacDonald-Hull SM, Parkin SM, Cunliffe WJ. Autoantibodies in alopecia areata (abstr). J Invest Dermatol 1993; 101: 475.
49. Imai R, Miura J, Numata K, Aikawa Y, Takamori K, Ogawa H. Analysis of T cell, activated T cell and NK cell subsets in peripheral blood lymphocytes from patients with alopecia areata. Nouv Dermatol 1988; 7 (suppf 1): 51.
50. Baadsgaard O, Lindskov R. Circulating lymphocyte subsets in patients with alopecia areata. Acta Derm Venereol 1986; 66: 266-8.
51. McDonagh AJG, Elliott KR, Messenger AG. Cytokines and dermal papilla function in alopecia areata. J Invest Dermatol 1995; 104: 9S-10S.
52. Happle R, Hoffmann R. Cytokine patterns in alopecia areata before and after topical immunotherapy. J Invest Dermatol 1995; 104: 14S-5S.
53. Messenger AG, Bleehen SS. Expression of HLA-DR by anagen hair follicles in alopecia areata. J Invest Dermatol 1985; 85: 569-76.
54. Fenton DA, Tobin DJ, Kendall MD. Role of the thymus gland in alopecia areata. J Invest Dermatol 1995; 104: 25S-6S.
55. Hordinsky MK, Kalish RS. Autoreactive cells in alopecia areata. J Invest Dermatol 1991; 96: 93S-4S.
56. Hoffmann R, Huth A, Wenzel E, Van der Steen P, Schäuffle M, Raykowski S, Happle R. Preferential use of T-cell receptor Vβ-chain genes in alopecia areata totalis. Eur J Dermatol 1996; 6: 65-9.
57. Skinner RB, Light WH, Bate GF, Rosenberg EW, Leonardi C. Alopecia areata and cytomegalovirus DNA (letter). JAMA 1995; 273: 1419-20.
58. Hordinsky MK, Kennedy W, Wendelschafer-Crabb G, Lewis S. Structure and function of cutaneous nerves in alopecia areata. J Invest Dermatol 1995; 104: 28S-9S.
59. Michie HJ, Jahoda CA, Oliver RF, Johnson BE. The DEBR rat: an animal model of human alopecia areata. Br J Dermatol1991; 125: 94-100.
60. McElwee KJ, Pickett P, Oliver F. The DEBR rat, alopecia areata and autoantibodies to the hair follicle. Br J Dermatol 1996; 134: 55-63.
61. Sundberg JP, Cordy WR, King LE Jr. Alopecia areata in aging C3H/HeJ mice. J Invest Dermatol 1994; 102: 847-56.
62. Whiting DA. Histopathology of alopecia areata in horizontal sections of scalp biopsies. J Invest Dermatol 1995; 104: 26S-7S.
63. Fanti PA, Tosti A, Bardazzi F, Guerra L, Morelli R. Alopecia areata: a pathological study of non-responsive patients. Nouv Dermatol 1991; 10: 643-4.
64. Van Scott EJ. Morphologic changes in pilosebaceous units and anagen hairs in alopecia areata. J Invest Dermatol 1958; 31: 35-43.
65. Tobin DJ, Fenton DA, Kendall MD. Abnormal cortical cell differentiation produces the exclamation-mark hair shaft in acute alopecia areata. Nouv Dermatol 1991; 10: 652.
66. Messenger AG, Slater DN, Bleehen SS. Alopecia areata: alteration in the hair growth cycle and correlation with the follicular pathology. Br J Dermatol 1986; 114: 337-47.
67. Todes-Taylor N, Turner R, Wood GS, Stratte DT, Morhenn VB. T-cell subpopulations in alopecia areata. J Am Acad Dermatol 1984; 11: 216-23.
68. Kohchiyama A, Hatamochi A, Ueki H. Increased number of OKT6-positive dendritic cells in the hair follicles of patients with alopecia areata. Dermatologica 1985; 171: 327-31.
69. Goos M. Zur Histopathologie der Alopecia Areata. Arch Dermatol Forsch 1971; 240: 160-72.
70. Elieff D, Sundby S, Kennedy W, Hordinsky M. Decreased sweat-gland number and function in patients with alopecia areata. Br J Dermatol 1991; 125: 130-5.
71. Tobin DJ, Fenton DA, Kendall MD. Ultrastructural observations of the hair bulb melanocytes and melanosomes in acute alopecia areata. J Invest Dermatol 1990; 94: 803-7.
72. Nutbrown M, MacDonald-Hull SP, Cunliffe WJ, Randall VA. Abnormalities in the ultrastucture of melanocytes and the outer root sheath of clinically normal hair follicles from alopecia areata scalps. J Invest Dermatol 1995; 104: 12S-3S.
73. Nutbrown M, MacDonald-Hull SP, Cunliffe WJ, Randall VA. Abnormalities in the dermal papilla from clinically normal hair follicles of alopecia areata patients may indicate an aetiological role in the disease (abstr). Br J Dermatol 1993 ; 129: 479.
74. McDonagh AJG, Cawood L, Messenger AG. Expression of extracellular matrix in hair follicle mesenchyme in alopecia areata. Br J Dermatol 1990; 123: 717-24.
75. Randall VA, MacDonald-Hull SP, Nutbrown M, Calver NS, Parkin SM, Cunliffe WJ. Is the dermal papilla a primary target in alopecia areata? J Invest Dermatol 1995; 104: 7S-8S.
76. Tobin DJ, Fenton DA, Kendall MD. Ultrastructural identification of increased cell death in acute alopecia areata. Nouv Dermatol 1991; 10: 643.
77. Nickoloff BJ, Griffiths CEM. Aberrant intercellular adhesion molecule-1 (ICAM-1) expression by hair-follicle epithelial cells and endothelial leukocyte adhesion molecule-1 (ELAM-1) by vascular cells are important adhesion-molecule alterations in alopecia areata. J Invest Dermatol 1991; 96: 91S-2S.
78. van Baar HM, Perret CM, van Vlijmen IM, van de Kerkhof PCM, Happle R. Abnormal expression of Ki-67 antigen in hair follicles of alopecia areata. Acta Derm Venereol (Stockh) 1992; 72: 161-4.
79. van Baar HM, van Vlijmen IM, Ramaekers FCS, van Muijen GNP, Troyanovsky SM, Perret CM, van de Kerkhof PCM, Schalkwijk J. Cytokeratin expression in alopecia areata hair follicles. Acta Derm Venereol (Stockh) 1994; 74: 28-32.
80. Lotti T, Teofoli P, Senesi C, Fedi AM, Bonan P, Palleschi GM, Panconensi E. The role of plasminogen activators in alopecia areafa. Int J Dermatol 1991; 30: 19-21.
81. Healy E, Rogers S. PUVA treatment for alopecia areata - does it work? A retrospective review of 102 cases. Br J Dermatol 1993;129: 42-4.
82. Fiedler VC. Alopecia areata: current therapy. J Invest Dermatol 1991; 96: 69S-70S.
83. Fiedler-Weiss VC, Buys CM. Evaluation of anthralin in the treatment of alopecia areata. Arch Dermatol 1987; 123: 1491-7.
84. Winter RJ, Kern F, Blizzard EM. Prednisolone therapy for alopecia areata. Arch Dermatol 1976; 122: 1549-83.
85. Montes LF. Topical halocinonide in alopecia areata and in alopecia totalis. J Cutan Pathol 1977; 4: 47-53.
86. Savaya ME, Hordinsky MK. Glucocorticoid regulation of hair growth in alopecia areata. J Invest Dermatol 1995; 104: 30S.
87. Lassus A, Eskwlinen A, Johansson E. Treatment of alopecia areata with three different PUVA modalities. Photodermatol 1984; 1: 141-50.
88. Claudy A, Gagnaire D. PUVA treatment for alopecia areata. Arch Dermatol 1983; 119: 975-8.
89. Taylor CR, Hawk JLM. PUVA treatment of alopecia areata partialis, totalis and universalis: audit of 10 years' experience at St John's Institute of Dermatology. Br J Dermatol 1995; 133: 914-8.
90. Happle R. Topical immunotherapy in alopecia areata. J Invest Dermatol 1991; 96: 71S-2S.
91. Happle R. Antigenic competition as a therapeutic concept for alopecia areata. Arch Dermatol Res 1980; 267: 109-14.
92. Gülekon A, Gürer MA, Bozkurt M, Keskin N. The effects of DNCB therapy on the T-Cell subsets of the cases with alopecia areata (corresp). Int J Dermatol 1989; 28: 684-5.
93. Happle R, Kalvaran KJ, Büchner U, Echternach-Happle K, Göggelmann W, Summer KH. Contact allergy as a therapeutic tool for alopecia areata; application of squaric acid dibutyl ester. Dermatologica 1980; 161: 289-94.
94. Orecchia G, Malagoli P. Topical immunotherapy in children with alopecia areata. J Invest Dermatol 1995; 104: 35S-6S.
95. MacDonald-Hull S, Norris JF. Diphencyprone in the treatment of long-standing alopecia areata. Br J Dermatol 1988; 119: 367-74.
96. MacDonald-Hull S, Pepall L, Cunliffe WJ. Alopecia areata in children: response to treatment with diphencyprone. Br J Dermatol 1991; 125: 164-8.
97. Hoting E, Boehm A. Therapy of alopecia areata with diphencyprone. Br J Dermatol 1992; 127: 625-9.
98. Bröcker EB, Echternacht-Happle K, Hamm H, Happle R. Abnormal expression of class I and class II major histocompatibility antigens in alopecia areata: modulation by topical immunotherapy. J Invest Dermatol 1987; 88: 564-8.
99. Henderson CA, Ilchyshyn A. Vitiligo complicating diphencyprone sensitization therapy for alopecia universalis. Br J Dermatol 1995; 133: 496-7.
100. Shapiro J, Tan J, Ho V, Tron V. Treatment of severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathologic evaluation. J Invest Dermatol 1995; 104: 36S.
101. Gupta AK, Ellis CN, Cooper KD, Nickoloff B, Ho V, Chan L, Hamilton T, Tellner D, Griffiths C, Voorhees J. Oral cyclosporin for the treatment of alopecia areata. J Am Acad Dermatol 1990; 22: 242-8.
102. De Prost Y, Teillac D, Plaquez F. Placebo controlled trial of topical cyclosporin in severe alopecia areata. Lancet 1986; ii: 803-4.
103. Monti M, Barbareschi M, Caputo R. Alopecia universalis in liver transplant patients treated with cyclosporin. Br J Dermatol 1995; 133: 663-4.
104. Thiers BH. Isoprinosine treatment of alopecia areata. J Invest Dermatol 1991; 96: 72S-3S.
105. Fenton DA, Wilkinson JD. Alopecia areata treated with topical minoxidil. J Roy Soc Med 1982; 75: 963-5.
106. Weiss VC, West DO, Fu TS, Robinson L, Cook B, Cohen R, Chambers D. Alopecia areata treated with topical minoxidil. Arch Dermatol 1984; 120: 457-66.
107. Fiedler VC, Buys CM. Immunohistochemical characterization of the cellular infiltrate in severe alopecia areata before and after minoxidil treatment. Dermatologica 1987; 175: 29-35.
108. Khoury EL, Price VH, Abdel-Salam MM, Stern M, Greenspan JS. Topical minoxidil in alopecia areata: no effect on the perifollicular lymphoid infiltration. J Invest Dermatol 1992; 99: 40-7.